Drug or treatment
Tildrakizumab clinical trials
As of November 12, 2026, Find a Trial lists 5 clinical trials of Tildrakizumab that are recruiting, at sites in 3 countries (most in Austria (2), United States (2), Canada (1)). By phase: Phase 4 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 5Clinical trials
- 3Countries
Newest trials
| Study | Phase | Where | Status | Registered |
|---|---|---|---|---|
| Tildrakizumab for symptoms and quality of life in Canadians with moderate-to-severe plaque psoriasis (Fitzpatrick III+) | — | Burlington, Ontario and 6 other locations | Recruiting | Jan 27, 2026 |
| Switching to Tildrakizumab for Moderate to Severe Plaque Psoriasis | — | Graz, Styria | Recruiting | Sep 8, 2023 |
| Evaluating Tildrakizumab for Genital Psoriasis Treatment | — | Graz, Styria | Recruiting | Sep 8, 2023 |
| Assessing immune response in psoriasis patients treated with Tildrakizumab | Phase 4 | San Francisco, California | Recruiting | May 25, 2022 |
| Assessing pregnancy outcomes in women treated with tildrakizumab | — | San Diego, California | Recruiting | Jun 20, 2019 |
All recruiting trials (5)
-
Tildrakizumab for symptoms and quality of life in Canadians with moderate-to-severe plaque psoriasis (Fitzpatrick III+)
This study will test how tildrakizumab affects symptoms, safety, and quality of life in adults in Canada with moderate-to-severe plaque psoriasis who are starting treatment through the ILUMYA SUPPORT® Program and have Fitzpatrick skin types III or higher.
-
Switching to Tildrakizumab for Moderate to Severe Plaque Psoriasis
This study tests if switching patients with moderate to severe plaque psoriasis to a new medication called tildrakizumab can improve their skin condition and quality of life.
-
Evaluating Tildrakizumab for Genital Psoriasis Treatment
This study is testing if a new medication called tildrakizumab can help people with genital psoriasis feel better and improve their quality of life.
-
Assessing immune response in psoriasis patients treated with Tildrakizumab
This study tests how the medication Tildrakizumab affects the immune system in people with moderate to severe psoriasis by looking at their skin and blood before and after treatment.
-
Assessing pregnancy outcomes in women treated with tildrakizumab
This study is trying to see how pregnancy and baby outcomes are affected in women who took tildrakizumab compared to those who didn't.
Quick answers
How many clinical trials of Tildrakizumab are recruiting right now?
5, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 3 countries. The most sites are in Austria (2 trials), United States (2 trials), Canada (1 trial). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 4: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.